One received lifestyle modifications alone
However, with the more recently introduced SGLT2 inhibitors and GLP-1 receptor agonists having shown impressive cardiovascular risk reduction in addition to glycemic control efficacy, these newer agents may also be considered as first-line therapies in patients with pre-existing cardiovascular or renal disease (Garber 2020)
These surgeries not only limit food intake but also reset hormonal signals, improve insulin sensitivity, and restore natural metabolic balancedelivering benefits that medications alone cannot achieve
But note that those are the parameters for the general public and your doctor will likely tailor the recommendations specifically to your case
Conditions such as reflux, gastritis, or delayed gastric emptying can make symptoms worse
While there is evidence that some ingredients may promote GLP-1 production in the body 8,9 , there is little evidence that these can reduce body fat long-term 10